MacroGenics, Inc. (MGNX)

MacroGenics Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue	175.14	149.5	149.96	58.75	151.94	77.45
Revenue Growth	21.65%	-0.31%	155.26%	-61.33%	96.19%	-26.16%
Cost of Revenue	176.45	183.18	189.49	174.81	214.41	217.23
Gross Profit	-1.3	-33.68	-39.53	-116.06	-62.47	-139.78
Selling, General & Admin	36.75	39.16	71.05	52.19	58.95	63.01
Operating Expenses	36.75	39.16	71.05	52.19	58.95	63.01
Operating Income	-38.06	-72.84	-110.58	-168.24	-121.42	-202.8
Interest Expense	-16.9	-8.51	-1.12	-1.43	-	-
Interest & Investment Income	5.89	6.06	9.42	9.69	1.66	0.68
Other Non Operating Income (Expenses)	-	-	-	150.93	-	-
EBT Excluding Unusual Items	-49.07	-75.29	-102.27	-9.06	-119.76	-202.12
Gain (Loss) on Sale of Assets	-	-	36.25	-	-	-
Pretax Income	-101.83	-75.29	-66.02	-9.06	-119.76	-202.12
Income Tax Expense	-0.78	-0.67	0.94	-	-	-
Net Income	-14.59	-74.62	-66.97	-9.06	-119.76	-202.12
Net Income to Common	-14.59	-74.62	-66.97	-9.06	-119.76	-202.12
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	63	63	63	62	61	60
Shares Outstanding (Diluted)	63	63	63	62	61	60
Shares Change	0.77%	0.85%	1.12%	0.81%	2.48%	14.31%
EPS (Basic)	-0.23	-1.18	-1.07	-0.15	-1.95	-3.37
EPS (Diluted)	-0.23	-1.18	-1.07	-0.15	-1.95	-3.37
EPS Growth	-	-	-	-	-	-
Free Cash Flow	-65.54	-82.95	-72.08	-79.97	-90.58	-150.03
Free Cash Flow Per Share	-1.03	-1.31	-1.15	-1.29	-1.47	-2.50
Gross Margin	-0.74%	-22.53%	-26.36%	-197.54%	-41.11%	-180.49%
Operating Margin	-21.73%	-48.72%	-73.74%	-286.38%	-79.91%	-261.85%
Profit Margin	-8.33%	-49.91%	-44.66%	-15.42%	-78.82%	-260.97%
Free Cash Flow Margin	-37.42%	-55.49%	-48.07%	-136.12%	-59.62%	-193.72%
EBITDA	-32.17	-65.67	-103.04	-158.6	-109.55	-191.54
EBITDA Margin	-18.37%	-43.93%	-68.71%	-269.96%	-72.10%	-247.31%
D&A For EBITDA	5.89	7.17	7.54	9.65	11.87	11.26
EBIT	-38.06	-72.84	-110.58	-168.24	-121.42	-202.8
EBIT Margin	-21.73%	-48.72%	-73.74%	-286.38%	-79.91%	-261.85%
Revenue as Reported	175.14	149.5	149.96	58.75	151.94	77.45

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: May 13, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 17, 2026

Data Sources Report a data error